Analyses of vaccine-specific circulating and bone marrow-resident B cell populations reveal benefit of delayed vaccine booster dosing with blood-stage malaria antigens

Barrett JR., Silk SE., Mkindi CG., Kwiatkowska KM., Hou MM., Lias AM., Kalinga WF., Mtaka IM., McHugh K., Bardelli M., Davies H., King LDW., Edwards NJ., Chauhan VS., Mukherji P., Rwezaula S., Chitnis CE., Olotu AI., Minassian AM., Draper SJ., Nielsen CM.

DOI

10.1101/2023.03.17.23287040

Type

Preprint

Publication Date

2023-03-24T00:00:00+00:00

Permalink More information Close